References
<A NAME="RU02904ST-1">1</A>
This report is Part 6 in the series ‘Synthetic studies of proanthocyanidins’.
<A NAME="RU02904ST-2">2</A>
Harborne JB.
The Flavonoids: Advances in Research from 1986
Chapman and Hall;
London:
1993.
<A NAME="RU02904ST-3">3</A>
Harborne JB.
Baxter H.
The Handbook of Natural Flavonoids
John Wiley and Sons;
New York:
1999.
<A NAME="RU02904ST-4">4</A>
Ariga T.
Koshiyama I.
Fukushima D.
Agric. Biol. Chem.
1988,
52:
2717
<A NAME="RU02904ST-5">5</A>
Zhao J.
Wang J.
Chen Y.
Agarwal R.
Carcinogenesis
1999,
20:
1737
<A NAME="RU02904ST-6">6</A>
Baba S.
Osakabe N.
Natsume M.
Terao J.
Free Radical Biol. Med.
2002,
33:
142
<A NAME="RU02904ST-7">7</A>
Sano A.
Yamakoshi J.
Tokutake S.
Tobe K.
Kubota Y.
Kikuchi M.
Biosci., Biotechnol., Biochem.
2003,
67:
1140
<A NAME="RU02904ST-8">8</A>
Saito A.
Nakajima N.
Tanaka A.
Ubukata M.
Heterocycles
2003,
61:
287
<A NAME="RU02904ST-9">9</A> Part 5:
Saito A.
Nakajima N.
Matsuura N.
Tanaka A.
Ubukata M.
Heterocycles
2004,
62:
479
<A NAME="RU02904ST-10">10</A>
Saito A.
Nakajima N.
Tanaka A.
Ubukata M.
Tetrahedron Lett.
2003,
44:
5449
<A NAME="RU02904ST-11A">11a</A>
Thompson RS.
Jacques D.
Haslam E.
Tanner RJN.
J. Chem. Soc., Perkin Trans. 1
1972,
1387
<A NAME="RU02904ST-11B">11b</A>
Kolodziej H.
Phytochemistry
1989,
28:
3487
<A NAME="RU02904ST-11C">11c</A>
Hsu F.
Nonaka G.
Nishioka I.
Chem. Pharm. Bull.
1985,
33:
3293
<A NAME="RU02904ST-11D">11d</A>
Nonaka G.
Hsu F.
Nishioka I.
J. Chem. Soc., Chem. Commun.
1981,
781
<A NAME="RU02904ST-11E">11e</A>
Delcour A.
Vercruysse AR.
J. Inst. Brew.
1986,
92:
244
<A NAME="RU02904ST-11F">11f</A>
Balas L.
Vercauteren J.
Magn. Reson. Chem.
1994,
32:
386
<A NAME="RU02904ST-11G">11g</A>
Hemingway RW.
Foo LY.
Porter LJ.
J. Chem. Soc., Perkin Trans. 1
1982,
1209
<A NAME="RU02904ST-12">12</A>
Saito A.
Nakajima N.
Tanaka A.
Ubukata M.
Tetrahedron
2002,
58:
7829
<A NAME="RU02904ST-13">13</A>
In this condensation reaction, excess amount (4.0-4.5 equiv) of a monomer nucleophile
was used to avoid higher oligomer formation.
<A NAME="RU02904ST-14">14</A>
Data for 7c: [α]D
26 -82.2 (c 0.12, CHCl3). 1H NMR (400 MHz, CDCl3, 0.83:0.17 mixture of rotational isomers) δ (major isomer) = 7.35-6.35 (57.27 H,
m), 6.11 (0.83 H, s), 6.10 (0.83 H, d, J = 2.2 Hz), 6.02 (0.83 H, d, J = 2.2 Hz), 6.00 (0.83 H, s), 5.17-4.33 (21.58 H, m), 4.19 (0.83 H, d, J = 8.8 Hz), 3.97-3.86 (1.66 H, m), 3.73-3.68 (0.83 H, m), 3.53 (0.83 H, d, J = 9.0 Hz), 3.03 (0.83 H, dd, J = 6.1 and 16.1 Hz), 2.89 (0.83 H, d, J = 9.6 Hz), 2.78 (0.83 H, dd, J = 9.7 and 16.1 Hz), 1.31 (0.83 H, d, J = 2.6 Hz, OH), 1.78 (0.83 H, d, J = 3.9 Hz, OH), 1.07 (0.83 H, d, J = 3.7 Hz, OH); δ (minor isomer) = 7.35-6.35 (11.22 H, m), 6.28 (0.17 H, d, J = 1.7 Hz), 6.21 (0.17 H, d, J = 8.3 Hz), 6.18 (0.17 H, s), 6.15 (0.17 H, s), 6.05 (0.17 H, d, J = 2.2 Hz), 5.97 (0.17 H, d, J = 2.2 Hz), 5.80 (0.17 H, dd, J = 1.7 and 8.3 Hz), 5.17-4.33 (5.27 H, m), 4.06-3.86 (0.34 H, m), 3.73-3.68 (0.17
H, m), 3.58-3.57 (0.17 H, m), 2.93 (0.17 H, d, J = 10.0 Hz), 2.66 (0.17 H, m), 2.37-2.32 (0.17 H, m), 1.44-1.41 (0.17 H, m, OH), 1.36-1.34
(0.17 H, m, OH), 1.20-1.17 (0.17 H, m, OH). 13C NMR (100 MHz, CDCl3): δ (major isomer) = 157.9, 157.8, 156.7, 155.5, 155.4, 155.1, 155.1, 154.9, 153.8,
149.2, 149.1, 149.0, 148.8 (× 2), 148.5, 137.6, 137.4, 137.4, 137.4, 137.3, 137.2,
137.2, 137.1, 137.1, 137.0, 136.0, 132.4, 132.3, 131.7, 128.8-126.9 (C × 37), 121.1,
120.6, 120.5, 115.0, 114.8, 114.7, 114.5, 114.1, 113.6, 112.2, 109.4, 108.6, 102.4,
101.1, 94.7, 93.8, 92.0, 91.8, 81.7, 81.0, 80.4, 73.0, 72.9, 71.9-69.8 (C × 11), 68.4,
65.2, 37.5, 37.4, 28.4; minor isomer was not identified. FAB-MS: m/z (%) = 1947 (0.26) [M + H]+. FAB-HRMS calcd for C129H110O18 [M + H]+: 1947.7770; found: 1947.7694.
<A NAME="RU02904ST-15">15</A>
Data for 7a: [α]D
25 -233.7 (c 0.38, EtOH) {lit.
[11a]
[α]578 -173 (c 1.03, EtOH)}; HPLC Rt 7a = 18.8 min. FAB-MS: m/z (%) = 890 (12.5), 889 (21.5) [M + Na]+, 888 (14.7), 887 (12.4), 868 (6.9), 867 (12.6) [M + H]+, 866 (10.9), 328 (100). FAB-HRMS calcd for C45H38O18Na [M + Na]+: 889.1956; found: 889.2018.
<A NAME="RU02904ST-16">16</A>
HPLC analysis conditions: Mightysil® RP-18 GP column (Kanto Chemical Co. Inc., Japan; 250 × 4.6 mm, 5µm); solvent (A)
0.1% CF3CO2H in MeCN, (B) 0.1% CF3CO2H in H2O: Elution was done with a linear gradient 5% to 100% A in 40 min (flow rate: 0.5
mL/min.).
<A NAME="RU02904ST-17">17</A>
Kolodziej H.
Plant Polyphenols
Hemingway RW.
Laks PE.
Plenum Press;
New York:
1992.
p.295-319
<A NAME="RU02904ST-18">18</A>
Balas L.
Vercauteren J.
Magn. Reson. Chem.
1995,
33:
85
<A NAME="RU02904ST-19">19</A>
Data for 1a: [α]D
25 +56.9 (c 0.30, EtOH) {lit.
[11c]
[α]D +76.9}; HPLC Rt 1a = 20.5 min. 1H NMR (400 MHz, CD3COCD3/D2O, 15/1): δ = 7.13-6.69 (9 H, br), 6.10-5.83 (4 H, br), 5.30-5.05 (1 H, br), 5.04-5.03
(1 H, br), 4.89-4.54 (3 H, br), 4.16-3.95 (3 H, br), 2.75-2.60 (1 H, br), 2.58-2.51
(1 H, br). FAB-MS: m/z (%) = 889 (12.8) [M + Na]+, 888 (7.1), 887 (5.8), 867 (9.0) [M + H]+, 866 (6.7), 329 (100). FAB-HRMS calcd for C45H38O18Na [M + Na]+: 889.1956; found: 889.1927.
<A NAME="RU02904ST-20">20</A>
Data for 4a: [α]D
24 -112.6 (c 0.40, MeOH) {lit.
[11d]
[a]D
27
-97.6 (c 1.0, MeOH)}; HPLC Rt 4a = 20.3 min. FAB-MS: m/z (%) = 890 (2.2), 889 (4.0) [M + Na]+, 888 (3.3), 887 (2.1), 868 (2.2), 867 (3.9) [M + H]+, 866 (3.1), 613 (4.2), 483 (11.7), 482 (25.2), 460 (48.2), 328 (100), 306 (100).
FAB-HRMS calcd for C45H38O18Na [M + Na]+: 889.1956; found: 889.1882.
<A NAME="RU02904ST-21">21</A>
Data for 2a: [α]D
27 +59.3 (c 0.30, MeOH) {lit. [α]D +70.4 (c 2.2, MeOH)}; HPLC20 Rt 2a = 22.0 min. FAB-MS: m/z (%) = 890 (1.9), 889 (3.3) [M + Na]+, 888 (2.2), 887 (1.7), 868 (1.6), 867 (3.3) [M + H]+, 866 (2.5), 613 (8.3), 482 (25.5), 459 (45.8), 328 (100), 306 (100). FAB-HRMS calcd
for C45H38O18Na [M + Na]+: 889.1956; found: 889.2031.
<A NAME="RU02904ST-22">22</A>
Kozikowski AP.
Tückmantel W.
Hu Y.
J. Org. Chem.
2003,
68:
1641